5: Movement disorders I: Parkinsonism and the akinetic-rigid syndromes

Medical Journal of Australia

Volumn 174, Issue 7, 2001, Pages 357-363

  Rice, J E ^a   Thompson, P D ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIEMETIC AGENT; ANTIPARKINSON AGENT; BROMOCRIPTINE; CABERGOLINE; CAFFEINE; CARBIDOPA; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOMPERIDONE; DOPA DECARBOXYLASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; ERGOT DERIVATIVE; FLUDROCORTISONE; FLUPHENAZINE; HALOPERIDOL; INDOMETACIN; ISPAGULA; LEVODOPA; NEUROLEPTIC AGENT; OLANZAPINE; PERGOLIDE; PERICIAZINE; PRAMIPEXOLE; PSEUDOEPHEDRINE; QUETIAPINE; ROPINIROLE; SELEGILINE; UNINDEXED DRUG;

AKINETIC RIGID SYNDROME; BRADYKINESIA; CLINICAL FEATURE; COGNITIVE DEFECT; DISABILITY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG RELEASE; DRUG TOLERABILITY; DYSKINESIA; HUMAN; HYPOTENSION; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NAUSEA; NEUROSURGERY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; PROGNOSIS; REVIEW; TREATMENT OUTCOME; TREMOR; VOMITING;

EID: 0035794828     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143316.x     Document Type: Review

References (30)

1. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
2. Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON collaborative study
3. The genetics of Parkinson's disease
4. Association between early-onset Parkinson's disease and mutations in the parkin gene
5. The Sydney multicentre study of Parkinson's disease: Progression and mortality at 10 years
6. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: A five year follow up
7. A five year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
8. The Sydney Multicentre Study of Parkinson's disease: A randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa
9. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial
10. Dopamine agonists in Parkinson's disease
11. Cabergoline in the treatment of early Parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa
12. Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease
13. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
14. International (NL-UK) double blind study of Sinemet CR and standard Sinemet (250/25) in 170 patients with fluctuating Parkinson's disease
15. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease
16. Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations
17. Double-blind comparison of pramipexole and bromocriptine with placebo in advanced Parkinson's disease
18. Cabergoline versus pergolide: A video blinded randomised multicenter cross-over study
19. The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease
20. Entacapone enhances the response to levodopa in Parkinson patients with motor fluctuations. Nomecomt study group
21. Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease
22. Amantadine for levodopa-induced dyskinesias - A 1-year follow-up study
23. Subcutaneous apomorphine in Parkinson's disease: Response to chronic administration for up to five years
24. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor
25. The effect of pallidotomy on voluntary movement in severe Parkinson's disease
26. Long term follow up of unilateral pallidotomy in advanced Parkinson's disease
27. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
28. Neural transplantation for neurodegenerative disorders
29. The gait disorder of subcortical arteriosclerotic encephalopathy (Binswanger's disease)
30. Clinical features and natural history of multiple system atrophy - An analysis of 100 cases